Abstract
Interest in generating human induced pluripotent stem (iPS) cells for stem cell modeling of diseases has overtaken that of patient-specific human embryonic stem cells due to the ethical, technical, and political concerns associated with the latter. In ophthalmology, researchers are currently using iPS cells to explore various applications, including: (1) modeling of retinal diseases using patient-specific iPS cells; (2) autologous transplantation of differentiated retinal cells that undergo gene correction at the iPS cell stage via gene editing tools (e.g., CRISPR/Cas9, TALENs and ZFNs); and (3) autologous transplantation of patient-specific iPS-derived retinal cells treated with gene therapy. In this review, we will discuss the uses of patient-specific iPS cells for differentiating into retinal pigment epithelium (RPE) cells, uncovering disease pathophysiology, and developing new treatments such as gene therapy and cell replacement therapy via autologous transplantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Borooah S, Phillips MJ, Bilican B et al (2013) Using human induced pluripotent stem cells to treat retinal disease. Prog Ret Eye Res 37:163–181
Carr AJ, Vugler AA, Hikita ST et al (2009) Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 4:e8152
Cereso N, Pequignot MO, Robert L et al (2014) Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient. Mol Ther Methods Clin Dev 1:14011. doi:10.1038/mtm.2014.11
Cho SW, Kim S, Kim JM et al (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotech 31:230–232
Cyranoski D (2013) Stem cells cruise to clinic. Nature 494:413
Fogerty J, Besharse JC (2011) 174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy. Invest Ophthalmol Vis Sci 52:7256–7266
Fu Y, Foden JA, Khayter C et al (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat biotech 31:822–826
Idelson M, Alper R, Obolensky A et al (2009) Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 5:396–408
Jin M, Li S, Moghrabi WN et al (2005) Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 122:449–459
Jin ZB, Okamoto S, Osakada F et al (2011) Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS one 6:e17084
Kameya S, Hawes NL, Chang B et al (2002) Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6. Hum Mol Genet 11:1879–1886
Li Y, Tsai YT, Hsu CW et al (2012) Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med 18:1312–1319
Li Y, Wu WH, Hsu CW et al (2014) Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Mol Ther 22(9):1688–1697. doi:10.1038/mt.2014.100
Lustremant C, Habeler W, Plancheron A et al (2013) Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis. Cell Reprogram 15:233–246
Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826
Pang JJ, Chang B, Hawes NL et al (2005) Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA). Mol Vis 11:152–162
Ran FA, Hsu PD, Lin CY et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380–1389
Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431
Schwartz SD, Hubschman JP, Heilwell G et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720. doi:10.1016/S0140-6736(12)60028-2
Singh R, Shen W, Kuai D et al (2013) iPS cell modeling of best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 22:593–607
Sonoda S, Spee C, Barron E et al (2009) A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc 4:662–673
Tsuji O, Miura K, Okada Y et al (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 107:12704–12709
Tucker BA, Mullins RF, Stone EM (2014) Stem cells for investigation and treatment of inherited retinal disease. Hum Mol Genet 23(R1):R9–R16. doi:10.1093/hmg/ddu124
Vasireddy V, Mills JA, Gaddameedi R et al (2013) AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One 8:e61396
Wang NK, Tosi J, Kasanuki JM et al (2010) Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa. Transplantation 89:911–919
Yang J, Li Y, Chan L et al (2014) Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Hum Mol Genet 23:3445–3455
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this paper
Cite this paper
Li, Y., Chan, L., Nguyen, H., Tsang, S. (2016). Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells. In: Bowes Rickman, C., LaVail, M., Anderson, R., Grimm, C., Hollyfield, J., Ash, J. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 854. Springer, Cham. https://doi.org/10.1007/978-3-319-17121-0_73
Download citation
DOI: https://doi.org/10.1007/978-3-319-17121-0_73
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17120-3
Online ISBN: 978-3-319-17121-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)